Celestial Therapeutics

Irvine, US · Founded 2019 · Delaware corporation

Celestial Therapeutics is a biotech company whose team works across genetics, virology, bioengineering, pulmonary surfactant lipid and protein chemistry, innate immunity, infectious diseases, and pharmacology. The available page provides only background on the founders' and team's expertise, without detailing specific products.

Biotech

Founders & leadership

Leontis TeryazosCFO and Corporate Secretary

Ajay GuptaPresident, CEO and Chairman of the Board

ANNELISE E BARRONDirector

AJAY GUPTAPresident, CEO and Chairman of the Board

LEONTIS TERYAZOSCFO and Corporate Secretary

George SiberDirector

Competitors · 7

by search overlap

PatSnap9 shared keywordsPatsnap builds an AI-powered platform for R&D, IP, and innovation intelligence, offering tools for patent search, novelty and FTO analysis, patent drafting, and materials and pharma research. It serves R&D leaders, IP professionals, engineers, and scientists across industries including materials, manufacturing, life sciences, pharmaceuticals, and consumer goods.

Kite Pharma5 shared keywords

Cartesian Therapeutics (NASDAQ: RNAC)5 shared keywordsCartesian Therapeutics develops mRNA-based cell therapies for autoimmune diseases. The company is a clinical-stage biotech firm focused on advancing immunology treatments through its proprietary mRNA platform.

Cowles_Investments_StemCentrx5 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.

Thepharmaletter5 shared keywords

Nasdaq Private Market4 shared keywordsNasdaq Private Market operates infrastructure for private-company securities, offering liquidity programs (tender offers, buybacks, auctions), a secondary marketplace for accredited investors to buy and sell pre-IPO shares and funds, market data and intelligence, patented settlement technology, and capital-raising solutions. It serves private companies, employee shareholders, institutional and individual investors, and banks/brokers.

Photo of Tempest Therapeutics4 shared keywords

Companies competing with Celestial Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements

▶$850KraisedJul 2026 · 11 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

Ajay GuptaExecutive Officer, Director
George SiberDirector
Leontis TeryazosExecutive Officer, Director

Amount sold: $850K
Minimum investment: $20K
First sale: Sep 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

▶$1.3MraisedApr 2024 · 13 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

ANNELISE E BARRONDirector
AJAY GUPTAExecutive Officer, Director
LEONTIS TERYAZOSExecutive Officer, Director

Amount sold: $1.3M
Minimum investment: $20K
Proceeds to insiders: $150K
First sale: Mar 2020
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2023	$290.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.